Advances in psychiatry and nuerology


ISSN 1234-8279

ISSN on-line 2449-9315 

 

As of July 2026, the journal's publisher is Wroclaw Medical University: https://ppn.umw.edu.pl/en/about/.

 

CiteScore 2025: 0.4

MNiSW: 20

Index Copernicus 2023: 90.54

Editorial panel
Submitting and reviewing works online
  • Home page
  • >
  • Archive
  • >
  • issue 4
  • >
  • Melatonine, antypical antyoxidant – role in Alzheimere’s disease – possible therapeutical use

Archive 1995–2023

2003, volume 19, issue 4
Article

Melatonine, antypical antyoxidant – role in Alzheimere’s disease – possible therapeutical use

Farmakoterapia w Psychiatrii i Neurologii, 2003, 4, 59-69
Keywords: Alzheimer’s disease, melatonine, antioxidants
Summary

Multiply aetiology has been proposed for Alzheimer’s disease. Besides hereditary, contagious hereditary, dietary and environmental factors are proposed. Neurohormones seem to play an important role in Alzheimer's disease pathology. Moreover, deficiency of melatonin is postulated to be important for the development of Alzheimer's disease. Melatonin is carried to the ventricular system via choroid plexus some of neurohormone is secreted directly into the cerebro-spinal fluid. The neurohormone is a potent antioxidant of an original mode of action. In Alzheimer's disease, inadequate melatonin allows hydroxyl radicals damage mitochondria and initiate a cascade of oxygen radicals that causes the neuropathological changes in Alzheimer's disease. Thus melatonin pathway can have role in neurodegenerative changes in the brain. Besides melatonin can have a role in the treatment of Alzheimer's disease.

You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links